Restart Life Sciences Corp. (NMLSF) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Vancouver, BC, Canada. The current CEO is Steve Loutskou.
NMLSF has IPO date of 2008-06-27, listed on the Other OTC, a market capitalization of $2.37M.
Restart Life Sciences Corp. is a biotechnology company, which engages in the research and development of psilocybin. It offers therapy and diagnostics for neuroinflammatory disorders. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
